ECONTRA EZ OTC
Generic Name and Formulations:
Levonorgestrel 1.5mg; tabs.
Indications for ECONTRA EZ:
Prevention of pregnancy after known or suspected contraceptive failure or unprotected intercourse. Not for use as regular contraceptive.
Rule out pregnancy first. ≥17yrs: Take one single-dose as soon as possible but no later than 72hrs after unprotected intercourse. If vomiting occurs within 2hrs, may consider repeating dose (consult physician).
<17yrs: not applicable.
See full labeling. Known or suspected pregnancy.
See full labeling. Ectopic pregnancy. Does not protect against HIV/AIDS or STDs.
Drugs (eg, barbiturates, carbamazepine, phenytoin) or herbal products (eg, St. John's wort) that induce certain enzymes (eg, CYP3A4) may decrease effectiveness.
Menstrual changes, nausea, vomiting, abdominal pain, fatigue, headache, dizziness, breast pain/tenderness.
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|
|Renal Cell Carcinoma||Regimens||Drugs|
Cancer Therapy Advisor Articles
- BRCA1/Shieldin Double Mutations May Signal Resistance to PARP Inhibitors
- Study Analyzing Postmarketing Data on Breast Implant Safety Sparks FDA Response
- Higher-Dose Immunoglobulin Replacement Therapy in Chronic Lymphocytic Leukemia
- Beyond BRCA: New Predisposition Genes Linked to Breast, Ovarian Cancers
- Finding Clinical Trials in Cancer
- Adding Nintedanib Did Not Improve Survival in Lung Cancer Subtype
- The Identification of a Potential Early Plasma Biomarker for Kidney Cancer
- Pembrolizumab Plus Chemotherapy Extended Survival Longer Than Chemotherapy Alone: Study
- Combining Chemotherapy With Checkpoint Inhibitors Extends Overall Survival in ES-SCLC
- In a Head-to-Head Battle, Brigatinib Appears to Best Crizotinib